Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMARCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYO6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAD2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD2AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP104 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC112 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUBPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPEPPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCYL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on